LIMK1 and pancreatic neoplasm: In pancreatic cancer, Vlecken and Bagowski (2009) reported that knockdown of LIMK1 can lead to an inhibition of invasion and metastatic behavior, as well as suppression of pancreatic cancer cell-induced angiogenesis.